Aktualne poglady na temat immunoprofilaktyki mykoplazmowego zapalenia pluc u swin

• Autorzy: Truszczynski M , Pejsak Z.

Warianty tytułu

EN

Up-to-date opinions concerning immunoprophylaxis of mycoplasmal pneumonia in swine

• Języki publikacji: PL

Abstrakty

EN

The role of Mycoplasma (M.) hyopneumoniae in the pathogenesis of mycoplasmal pneumonia in swine (MPS), its importance in causing losses in swine production and the efficacy of specific bacterins in their reduction were described. The value of immunoprophylaxis in comparison to other procedures applied in the control of the disease was estimated. Cell-mediated immunity and mucosal immunity involving IgA located in the mucus of the bronchi were judged as important for protection against the disease. However, bacterins provide only partial protection and do not prevent the colonization and carriership of M. hyopneumoniae in the lungs. Research on new vaccines, including aerosol and feed-based vaccines, as well as subunit and DNA preparations were characterized. Finally, it was concluded that the application of vaccines in the control of MPS should be evaluated as a supplementary, economically acceptable method when combined with optimal herd management practices and housing conditions.

Słowa kluczowe

PL

trzoda chlewna; choroby zwierzat; choroby ukladu oddechowego; mykoplazmowe zapalenie pluc; Mycoplasma hyopneumoniae; mechanizmy chorobotworczosci; immunoprofilaktyka; szczepienia ochronne; szczepionki

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2009
• Tom: 65
• Numer: 03
• Opis fizyczny: s.155-159,bibliogr.

Twórcy

autor

Truszczynski M

• Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy, Al.Partyzantow 57, 24-100 Pulawy

autor

Pejsak Z.

Bibliografia

• 1.Assunção P., De la Fe C., Ramírez A. S., Gonzále Llamazares O., Poveda J. B.: Protein and antigenic variability among Mycoplasma hyopneumoniae strains by SDS-PAGE and immunoblot. Vet. Res. Commun. 2005, 29, 563-574.
• 2.Baccaro M., Hirose F., Umehara O., Gonçalves L., Doto D., Paixão R., Shinya L., Moreno A.: Comparative efficacy of two single-dose bacterins in the control of Mycoplasma hyopneumoniae in swine raised under commercial conditions in Brazil. Vet. J. 2006, 172, 526-531.
• 3.Bandrick M., Pieters M., Pijoan C., Molitor T.: Cellular immune response in piglets following sow vaccination with Mycoplasma hyopneumoniae, [w:] Proceedings of the Allen D. Leman Swine Conference, vol. 33, Supplement. College of Veterinary Medicine, University of Minnesota, Minneapolis MN, USA 2006, 11.
• 4.Bargen L.: A system response to an outbreak of enzootic pneumonia in grow/finish pigs. Can. Vet. J. 2004, 45, 856-859.
• 5.Boettcher T., Thacker B., Halbur P., Waters W., Nutsch R., Thacker E.: Vaccine efficacy and immune response to Mycoplasma hyopneumoniae challenge in pigs vaccinated against porcine reproductive and respiratory syndrome virus and M. hyopneumoniae. J. Swine Health Prod. 2002, 10, 259-264.
• 6.Burnett T., Dinkla K., Rohde M., Chatwal G., Uphoff C., Srivastava M., Cordwell S., Geary S., Liao X., Minion C., Walker M., Djordjevic S.: P159 is a proteolytic processed surface adhesin of Mycoplasma hyopneumoniae: defined domains of P159 bind heparin and promote adherence to eukaryote cells. Mol. Microbiol. 2006, 60, 669-686.
• 7.Djordjevic S., Eamens G., Romalis L., Nicholls P., Taylor V., Chin J.: Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant. Aust. Vet. J. 1997, 75, 504-511.
• 8.Dohoo I. R., Montgomery M. F.: A field trial to evaluate a Mycoplasma hyopneumoniae vaccine: Effects on lung lesions and growth rates in swine. Can. Vet. J. 1996, 37, 299-302.
• 9.Fagan P., Walker M., Chin J., Eamens G., Djordjevic S.: Oral immunization of swine with attenuated Salmonella Typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrDF specific secretory IgA response in the lungs. Microb. Pathogenesis 2001, 30, 101-110.
• 10.Haruna J., Hanna P., Hurnik D., Ikede B., Miller L., Yason C.: The role of immunostimulation in the development of postweaning multisystemic wasting syndrome in pigs under field conditions. Can. J. Vet. Res. 2006, 70, 269-276.
• 11.Hodgins D., Shewen P., Dewey C.: Influence of age and maternal antibodies on antibody responses of neonatal piglets vaccinated against Mycoplasma hyopneumoniae. J. Swine Health Prod. 2004, 12, 10-16.
• 12.Jayappa H., Davis B., Rapp-Gabrielson V., Wasmoen T., Thacker E.: Evaluation of the efficacy of Mycoplasma hyopneumoniae bacterin follwoing immunization of young pigs in the presence of varying levels of maternal antibodies. Proc. 32nd Annual Meeting, Am. Assoc. Swine Vet., Nashville, Tennessee 2001, 237-241.
• 13.Jensen D., Ersboll A., Nielsen J.: A meta-analysis comparing the effect of vaccines against Mycoplasma hyopneumoniae on daily weight gain in pigs. Prev. Vet. Med. 2002, 54, 265-278.
• 14.Jones G., Rapp-Gabrielson V., Wilke R., Thacker E., Thacker B., Gergen L., Sweeney D., Wasmoen T.: Intradermal vaccination for Mycoplasma hyopneumoniae. J. Swine Health Prod. 2004, 13, 19-27.
• 15.Kołodziejczyk P., Loda M., Kwaczyński R., Czapla R.: Skuteczność szczepionki Porcilis M w zwalczaniu mykoplazmowego zapalenia płuc u świń. Magazyn Wet. 2006, 6, 76-77.
• 16.Lin J., Weng C., Liao C., Yeh K., Pan M.: Protective effects of oral microencapsulated Mycoplasma hyopneumoniae vaccine prepared by co-spray drying method. J. Vet. Med. Sci. 2003, 65, 69-74.
• 17.Maes D., Deluyker H., Verdonck M., Castryck F., Miry C., Lein A., Vrijens B., de Kruif A.: Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with a continuous production system. J. Vet. Med. B 1998, 45, 495-505.
• 18.Maes D., Deluyker H., Verdonck M., Castryck F., Miry C., Vrijens B., Verbeke W., Viaene J., de Kruif A.: Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with an all-in/all-out production system. Vaccine 1999, 17, 1024-1034.
• 19.Maes D., Segales J., Meyns T., Sibila M., Pieters M., Haesebrouck F.: Control of Mycoplasma hyopneumoniae infections in pigs. Vet. Microbiol. 2008, 126, 297-309.
• 20.Maes D., Verbeke W., Vicca J., Verdonck M., de Kruif A.: Benefit to cost of vaccination against Mycoplasma hyopneumoniae in pig herds under Belgian market conditions from 1996 to 2000. Livest. Prod. Sci. 2003, 83, 85-93.
• 21.Martelli P., Terreni M., Guazzetti S., Cavirani S.: Antibody response to Mycoplasma hyopneumoniae infection in vaccinated pigs with or without maternal antibodies induced by sow vaccination. J. Vet. Med. B 2006, 53, 229-233.
• 22.Meyns T., Dewulf J., de Kruif A., Calus D., Haesebrouck F., Mae D.: Comparison of transmission of Mycoplasma hyopneumoniae in vaccinated and non-vaccinated populations.Vaccine 2006, 24, 7081-7086.
• 23.Meyns T., Maes D., Calus D., Ribbens S., Dewulf J., Chiers K., de Kruif A., Cox E., Decostere A., Haesebrouck F.: Interactions of highly and low virulent Mycoplasma hyopneumoniae isolates with the respiratory tract of pigs. Vet. Microbiol. 2007, 120, 87-95.
• 24.Murphy D., Van Alstine W., Clark K., Albregts S., Knox K.: Aerosol vaccination of pigs against Mycoplasma hyopneumoniae infection. Am. J. Vet. Res. 1993, 54, 1874-1880.
• 25.Opriessnig T., Yu S., Gallup J., Evans R., Fenaux M., Pallares F., Thacker E., Brockus C., Ackermann M., Thomas P., Meng X., Halbur P.: Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus. Vet. Pathol. 2003, 41, 624-640.
• 26.Razin S., Yogev D., Naot Y.: Molecular biology and pathogenicity of Mycoplasmas. Microbiol. Mol. Biol. Rev. 1998, 62, 1094-1156.
• 27.Shimoji Y., Oishi E., Muneta Y., Nosaka H., Mori Y.: Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine. Vaccine 2003, 21, 532-537.
• 28.Sibila M., Berna R., Torrents D., Riera P., Llopart D., Calsamiglia M., Segalés J.: Effect of sow vaccination against Mycoplasma hyopneumoniae on sow and piglet colonization and seroconversion, and pig lung lesions at slaughter. Vet. Microbiol. 2008, 127, 165-170.
• 29.Sibila M., Bernal R., Torrent D., March R., Llopart D., Riera P., Calsamiglia M.: Effect of Mycoplasma hyopneumoniae sow vaccination on colonization, seroconversion and presence of enzootic pneumonia compatible lung lesions. Proc. 19th IPVS Congress, Copenhagen, Denmark 2006, s. 103.
• 30.Sibila M., Calsamiglia M., Vidal D., Badiella Ll., Aldaz Á., Jensen J. D.: Dynamics of Mycoplasma hyopneumonicae infection in twelve farms with different production systems. Can. J. Vet. Res. 2004a, 68, 12-18.
• 31.Sibila M., Nofrarías M., López-Soria S., Segalés J., Riera P., Llopart D., Calsamiglia M.: Exploratory field study on Mycoplasma hyopneumoniae infection in suckling pigs. Vet. Microbiol. 2007b, 121, 352-356.
• 32.Sibila M., Nofrarías M., López-Soria S., Segalés J., Valero O., Espinalm A., Calsamiglia M.: Chronological study of Mycoplasma hyopneumoniae infection, seroconversion and associated lung lesions in vaccinated and non-vaccinated pigs. Vet. Microbiol. 2007a, 122, 97-107.
• 33.Stakenborg T., Vicca J., Maes D., Peeters J., de Kruif A., Haesebrouck F., Butaye P.: Comparison of molecular techniques for the typing of Mycoplasma hyopneumoniae isolates. J. Microbiol. Methods 2006, 66, 263-275.
• 34.Tajima M., Yagihashi T., Nunoya T., Takeuchi A., Ohashi F.: Mycoplasma hyopneumoniae infection in pigs immunosuppressed by thymectomy and treatment with antithymocyte serum. Am. J. Vet. Res. 1984, 45, 1928-1932.
• 35.Tarasiuk K., Pejsak Z., Stadejek T., Błaszczyk B.: Skuteczność profilaktyki swoistej w zwalczaniu mykoplazmowego zapalenia płuc u świń. Medycyna Wet. 1992, 48, 402-405.
• 36.Thacker B., Thacker E., Halbur P., Minion C., Young T., Erickson B., Thanawonguwech T.: The influence of maternally-derived antibodies on Mycoplasma hyopneumoniae infection. Proc. 16th IPVS Congress, Melbourne, Australia 2000, s. 454.
• 37.Thacker E.: Mycoplasmal diseases, [w:] Straw B. E., Zimmerman J. J., D'Allaire S., Taylor D. J. (Eds.): Diseases of Swine. Blackwell Publishing Ltd., Oxford, UK 2006, 701-717.
• 38.Thacker E., Halbur P., Ross R., Thanawongnuwech R., Thacker B.: Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia. J. Clin. Microbiol. 1999, 37, 620-627.
• 39.Thacker E., Thacker B., Boettcher T., Jayappa H.: Comparison of antibody production, lymphocyte stimulation, and protection induced by four commercial Mycoplasma hyopneumoniae bacterins. J. Swine Health Prod. 1998, 6, 107-112.
• 40.Thacker E., Thacker B., Kuhn M., Hawkins P., Waters W.: Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs. Am. J. Vet. Res. 2000, 61, 1384-1389.
• 41.Thacker E., Thacker B., Young Th., Halbur P.: Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae. Vaccine 2000, 18, 1244-1252.
• 42.Truszczyński M., Pejsak Z.: Strategia stosowania szczepionek zależna od charakteru choroby zakaźnej. Medycyna Wet. 2008, 64, 619-622.
• 43.Vicca J., Thermote L., Maes D., D'Hooghe I., Peeters J., Haesebrouck F., de Kruif A.: Patterns of Mycoplasma hyopneumoniae infection in closed pig herds using serology and nested PCR on nasal samples. J. Vet. Med. B 2002, 49, 349-353.
• 44.Zhang Q., Young T. F., Ross R. F.: Identification and characterization of Mycoplasma hyopneumoniae adhesins. Infect. Immun. 1995, 62, 1616-1622.